Grierson H L, Skare J, Church J, Silberman T, Davis J R, Kobrinsky N, McGregor R, Israels S, McCarty J, Andrews L G
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha.
Am J Med Genet. 1993 Sep 15;47(4):458-63. doi: 10.1002/ajmg.1320470404.
The Epstein-Barr virus (EBV)-induced diseases of males with X-linked lymphoproliferative disease (XLP) include fatal infectious mononucleosis (IM), non-Hodgkin lymphoma (ML), agammaglobulinemia, and aplastic anemia. These phenotypes also occur as sporadic cases in families, and EBV seronegative males in these families must be considered at risk for XLP until they seroconvert normally to EBV. Given that 50% of males inheriting the defective XLP gene die following primary EBV infection, it is vital that they be identified pre-EBV infection. Here we report results using molecular genetic techniques to provide information as to the relative risks of EBV negative males and potential carrier females in ten families wherein a single male had died of IM.
爱泼斯坦-巴尔病毒(EBV)诱发的患有X连锁淋巴增生性疾病(XLP)的男性疾病包括致命性传染性单核细胞增多症(IM)、非霍奇金淋巴瘤(ML)、无丙种球蛋白血症和再生障碍性贫血。这些表型在家族中也以散发病例出现,在这些家族中,EBV血清学阴性的男性在血清正常转化为EBV之前必须被视为有患XLP的风险。鉴于50%继承有缺陷XLP基因的男性在原发性EBV感染后死亡,在EBV感染前识别他们至关重要。在此,我们报告使用分子遗传学技术的结果,以提供关于十个家族中EBV阴性男性和潜在携带者女性的相对风险的信息,在这些家族中,有一名男性死于IM。